Genmab revenue rises 25% in first half of 2026, guidance raised

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Genmab revenue rises 25% in first half of 2026, guidance raised
(NASDAQ: GMAB) Delayed: 34.69 -0.05 (0.14%)
Previous Close $34.74    52 Week High $ 
Open $34.70    52 Week Low $ 
Day High $34.87    P/E N/A 
Day Low $34.36    EPS $ 
Volume 1,577,456